ImpediMed Limited at it's general meeting approved removal of Donald Williams as a director of the Company, removal of Amit Patel as a director of the Company, removal of David Anderson as a director of the Company, removal of Daniel Sharp as a director of the Company with effect from September 28, 2023, appointment of McGregor Grant as a director of the Company with effect from September 28, 2023, appointment of Christine Emmanuel-Donnelly as a director of the Company, appointment of Andrew Grant as a director of the Company and appointment of Janelle Delaney as a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | -.--% | -6.17% | -47.59% |
Apr. 30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.59% | 102M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- Impedimed Limited Announces Board Changes